MedTrace Logo

oCular Examination at Cell RESolution With Optical TransmissionTomography

NCT06976034 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2025-05-16

No results posted yet for this study

Summary

Understanding the pathogenesis of eye diseases has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems, such as optical coherence tomography (OCT), are limited in terms of resolution, acquisition speed or access to certain eye functions. Our team has participated in the development of a new generation of imaging technology known as optical transmission tomography (OTT), which enables imaging of the anterior parts of the eye with high cellular resolution, a wide field of view and reduced examination delay.

Conditions

  • Glaucoma Associated With Other Ocular Disorders

Interventions

DEVICE

Optical Transmission Tomography (OTT)

Multiple imaging sessions added by research using the systems described (OTT) will be carried out by two different operators at different positions during these sessions.

DEVICE

Optical Coherence Tomography (OCT)

Multiple imaging sessions (OCT) already used in standard of care will be performed by two different operators at different positions during these sessions.

DEVICE

Specular Microscopy (SM)

Multiple imaging sessions (SM) already used in standard of care will be performed by two different operators at different positions during these sessions.

Sponsors & Collaborators

  • Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

    lead OTHER

Principal Investigators

  • Nacim BOUHERAOUA, PU-PH · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-11-12
Primary Completion
2029-11-12
Completion
2029-11-12

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06976034 on ClinicalTrials.gov